Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?

  • Chappuis F
  • Sundar S
  • Hailu A
 et al. 
  • 1

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

Visceral leishmaniasis (VL) is a systemic protozoan disease that is transmitted by phlebotomine sandflies. Poor and neglected populations in East Africa and the Indian subcontinent are particularly affected. Early and accurate diagnosis and treatment remain key components of VL control. In addition to improved diagnostic tests, accurate and simple tests are needed to identify treatment failures. Miltefosine, paromomycin and liposomal amphotericin B are gradually replacing pentavalent antimonials and conventional amphotericin B as the preferred treatments in some regions, but in other areas these drugs are still being evaluated in both mono- and combination therapies. New diagnostic tools and new treatment strategies will only have an impact if they are made widely available to patients.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • François Francois Chappuis

  • Shyam Sundar

  • Asrat Hailu

  • Hashim Ghalib

  • Suman Rijal

  • Rosanna W Peeling

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free